Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Solventum Corp (NYSE: SOLV) was $85.27 for the day, down -0.58% from the previous closing price of $85.77. In other words, the price has decreased by -$0.58 from its previous closing price. On the day, 0.99 million shares were traded. SOLV stock price reached its highest trading level at $86.81 during the session, while it also had its lowest trading level at $85.251.
Ratios:
Our analysis of SOLV’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.01 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 295.80. For the most recent quarter (mrq), Quick Ratio is recorded 1.14 and its Current Ratio is at 1.50. In the meantime, Its Debt-to-Equity ratio is 1.03 whereas as Long-Term Debt/Eq ratio is at 1.03.
Upgrades & Downgrades
In the most recent recommendation for this company, UBS on October 01, 2025, initiated with a Neutral rating and assigned the stock a target price of $77.
On September 11, 2025, Jefferies started tracking the stock assigning a Hold rating and target price of $80.
Morgan Stanley Upgraded its Equal-Weight to Overweight on July 15, 2025, while the target price for the stock was maintained at $103.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 15 ’25 when 3M CO sold 8,800,000 shares for $73.45 per share. The transaction valued at 646,360,000 led to the insider holds 25,569,190 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SOLV now has a Market Capitalization of 14789872640 and an Enterprise Value of 18284873728. As of this moment, Solventum’s Price-to-Earnings (P/E) ratio for their current fiscal year is 9.82, and their Forward P/E ratio for the next fiscal year is 13.43. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 10.02. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.76 while its Price-to-Book (P/B) ratio in mrq is 2.97. Its current Enterprise Value per Revenue stands at 2.176 whereas that against EBITDA is 14.523.
Stock Price History:
The Beta on a monthly basis for SOLV is 0.30, which has changed by 0.1924206 over the last 52 weeks, in comparison to a change of 0.12934029 over the same period for the S&P500. Over the past 52 weeks, SOLV has reached a high of $86.28, while it has fallen to a 52-week low of $60.70. The 50-Day Moving Average of the stock is 16.27%, while the 200-Day Moving Average is calculated to be 16.73%.
Shares Statistics:
SOLV traded an average of 1.08M shares per day over the past three months and 1281940 shares per day over the past ten days. A total of 173.44M shares are outstanding, with a floating share count of 147.65M. Insiders hold about 14.87% of the company’s shares, while institutions hold 72.24% stake in the company. Shares short for SOLV as of 1763078400 were 4090907 with a Short Ratio of 3.78, compared to 1760486400 on 4433291. Therefore, it implies a Short% of Shares Outstanding of 4090907 and a Short% of Float of 2.94.
Earnings Estimates
As of right now, 11.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $1.48, with high estimates of $1.54 and low estimates of $1.43.
Analysts are recommending an EPS of between $6.05 and $6.0 for the fiscal current year, implying an average EPS of $6.02. EPS for the following year is $6.35, with 13.0 analysts recommending between $6.5 and $6.15.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 9 analysts. It ranges from a high estimate of $1.97B to a low estimate of $1.94B. As of. The current estimate, Solventum Corp’s year-ago sales were $2.07BFor the next quarter, 9 analysts are estimating revenue of $1.95B. There is a high estimate of $1.98B for the next quarter, whereas the lowest estimate is $1.93B.
A total of 12 analysts have provided revenue estimates for SOLV’s current fiscal year. The highest revenue estimate was $8.3B, while the lowest revenue estimate was $8.14B, resulting in an average revenue estimate of $8.27B. In the same quarter a year ago, actual revenue was $8.25BBased on 12 analysts’ estimates, the company’s revenue will be $7.98B in the next fiscal year. The high estimate is $8.05B and the low estimate is $7.68B.
